Company intelligence / Profile preview

The ROS1ders

Sacramento, California, United States

Ownership: Private
Development stage: Other

Overview

The ROS1ders is a U.S.-based, globally active 501(c)(3) nonprofit organization focused on improving outcomes for people with ROS1-positive cancers. Founded by patients, it provides community support, patient education, research advocacy, and clinician/researcher engagement centered on ROS1-driven disease. The organization helps connect patients to clinical knowledge and trials, supports real-world data and specimen/model generation efforts, and funds external ROS1 research through seed grants and innovation awards. Although it operates in oncology and precision medicine, it is not a therapeutic developer or commercial biotech company.

Therapeutic areas: Oncology
Industry: Academic Hospital/University/Research

Partnerships

LUNGevity FoundationPfizer Lung Cancer Steering CommitteeGlobal ROS1 Initiative collaborators

Beyond the preview

Go deeper on The ROS1ders.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on The ROS1ders.

Explore the full profile